Anita Buck

Dr. Anita Buck, Ph.D. is Senior Director IP Management at CureVac, a German biopharmaceutical company that develops therapies based on messenger RNA. She is European patent attorney, has a doctorate degree in human biology and a master’s degree in Intellectual Property Law and Management. Dr. Buck started at CureVac in 2006 and is very proud that she is part of a company that is “not just developing new drugs but a completely new technology that is able to revolutionize medicine”.